MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults

Jean Bousquet; Holger J. Schünemann; Peter W. Hellings; Sylvie Arnavielhe; Claus Bachert; Anna Bedbrook; Karl-Christian Bergmann; Sinthia Bosnic-Anticevich; Jan Brozek; Moises Calderon; G. Walter Canonica; Thomas B. Casale; Niels H. Chavannes; Linda Cox; Henry Chrystyn; Alvaro A. Cruz; Ronald Dahl; Giuseppe de Carlo; Pascal Demoly; Philippe Devillier; Gérard Dray; Monica Fletcher; Wytske J. Fokkens; Joao Fonseca; Sandra N. Gonzalez-Diaz; Lawrence Grouse; Thomas Keil; Piotr Kuna; Désirée Larenas-Linnemann; Karin C. Lodrup Carlsen; Eli O. Meltzer; Joaquim Mullol; Antonella Muraro; Robert Naclerio; Susanna Palkonen; Nikolaos G. Papadopoulos; Giovanni Passalacqua; David Price; Dermot Ryan; Boleslaw Samolinski; Glenis K. Scadding; Aziz Sheikh; Arunas Valiulis; Erkka Valovirta; Samantha Walker; Magnus Wickman; Arzu Yorgancioglu; Torsten Zuberbier

doi:10.1016/j.jaci.2016.03.025

Retour

MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults

Article de revue

Avec comité de lecture

MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults

Jean Bousquet, Holger J. Schünemann, Peter W. Hellings, Sylvie Arnavielhe, Claus Bachert, Anna Bedbrook, Karl-Christian Bergmann, Sinthia Bosnic-Anticevich, Jan Brozek, Moises Calderon, …

Journal of Allergy and Clinical Immunology

03/2016

DOI: https://doi.org/10.1016/j.jaci.2016.03.025

Résumé

allergic rhinitis

conjunctivitis

ARIA

MACVIA-LR

ICT

clinical decision support system

The selection of pharmacotherapy for patients with allergic rhinitis depends on several factors, including age, prominent symptoms, symptom severity, control of allergic rhinitis, patient preferences and cost. Allergen exposure and resulting symptoms vary and treatment adjustment is required. Clinical decision support systems (CDSS) may be beneficial for the assessment of disease control. Clinical decision support systems should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine the treatment and its step-up or step-down strategy depending on AR control. MACVIA-LR (Fighting chronic diseases for active and healthy ageing) one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (MASK: MACVIA-ARIA Sentinel networK). A clinical decision support system is currently being developed to optimize allergic rhinitis control. An algorithm developed by consensus is presented in this paper. This algorithm should be confirmed by appropriate trials.

Fichiers et liens (1)

url

Find in HALAfficher

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults
Créateurs - sans rôle: Jean Bousquet - Hôpital Saint Eloi
Holger J. Schünemann - Departments of Clinical Epidemiology and Biostatistics and Medicine [Ontario]
Peter W. Hellings - Laboratory of clinical immunology
Sylvie Arnavielhe - Kyomed
Claus Bachert - Upper Airways Research Laboratory
Anna Bedbrook - Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon
Karl-Christian Bergmann - Secretary General of the Global Allergy and Asthma European Network
Sinthia Bosnic-Anticevich - Woolcock Institute of Medical Research
Jan Brozek - Departments of Clinical Epidemiology and Biostatistics and Medicine [Ontario]
Moises Calderon - National Heart Lung and Blood Institute
G. Walter Canonica - Allergy & Respiratory Diseases Clinic - DIMI
Thomas B. Casale - Division of Allergy/Immunology
Niels H. Chavannes - Department of Public Health and Primary Care [leiden]
Linda Cox - Department of Medicine [Floride]
Henry Chrystyn - RiRL
Alvaro A. Cruz - Aerospace Medical Association
Ronald Dahl - Department of Dermatology and Allergy Centre
Giuseppe de Carlo - European Federation of Allergy
Pascal Demoly - ESIM - Déterminants Sociaux de la Santé et du Recours aux Soins
Philippe Devillier - Laboratoire de Pharmacologie Respiratoire UPRES EA220
Gérard Dray - IMT Mines Alès
Monica Fletcher - Education for Health
Wytske J. Fokkens - Department of Otorhinolaryngology [Amsterdam]
Joao Fonseca - Center of Research in Health Technologies and Information Systems
Sandra N. Gonzalez-Diaz - Universidad Autónoma de Nuevo León
Lawrence Grouse - Faculty
Thomas Keil - Institute of Social Medicine
Piotr Kuna - Division of Internal Medicine, Asthma and Allergy
Désirée Larenas-Linnemann - Aerospace Medical Association
Karin C. Lodrup Carlsen - Department of Paediatrics [Oslo]
Eli O. Meltzer - Allergy & Asthma Medical Group & Research Center
Joaquim Mullol - Transverse group for research in primary care [Barcelona]
Antonella Muraro - Department of Women and Child Health
Robert Naclerio - Section of Otolaryngology-Head & Neck Surgery
Susanna Palkonen - European Federation of Allergy
Nikolaos G. Papadopoulos - Center for Pediatrics and Child Health
Giovanni Passalacqua - Allergy & Respiratory Diseases Clinic - DIMI
David Price - Academic Centre of Primary Care
Dermot Ryan - Allergy and Respiratory Research Group
Boleslaw Samolinski - Department of Prevention of Envinronmental Hazards and Allergology
Glenis K. Scadding - The Royal National TNE Hospital
Aziz Sheikh - Centre for Population Health Sciences
Arunas Valiulis - Vilnius University
Erkka Valovirta - Dept. of Lung Diseases and Clinical Allergology
Samantha Walker - King‘s College London
Magnus Wickman - The Institute of Environmental Medicine [Stockholm]
Arzu Yorgancioglu - Department of Pulmonology
Torsten Zuberbier - Secretary General of the Global Allergy and Asthma European Network
Détails de publication: Journal of Allergy and Clinical Immunology
Identifiants: 99160559209311
Unité académique: Université de Montpellier
Langue: English
Type de ressource: Journal article
Champs locaux: hal-01310973